Growth Metrics

Palisade Bio (PALI) Enterprise Value Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,692.12%
Dec 31, 2025 -1,256.13%
Sep 30, 2025 34.99%
Jun 30, 2025 52.29%
Mar 31, 2025 35.88%
Dec 31, 2024 21.47%
Sep 30, 2024 47.49%
Jun 30, 2024 30.79%
Mar 31, 2024 15.20%
Dec 31, 2023 -0.40%
Sep 30, 2023 -9.49%
Jun 30, 2023 -229.38%
Mar 31, 2023 -100.14%
Dec 31, 2022 -17.99%
Sep 30, 2022 0.84%
Jun 30, 2022 60.64%
Mar 31, 2022 -980.33%
Dec 31, 2021 -1,371.95%
Sep 30, 2021 -1,778.03%
Jun 30, 2021 -732.98%
Mar 31, 2021 93.87%
Dec 31, 2020 86.06%
Sep 30, 2020 89.71%
Jun 30, 2020 33.42%
Mar 31, 2020 -150.43%
Dec 31, 2019 11.62%
Sep 30, 2019 -27.24%
Jun 30, 2019 67.83%
Mar 31, 2019 58.81%
Dec 31, 2018 50.43%
Sep 30, 2018 59.21%
Jun 30, 2018 38.01%
Mar 31, 2018 41.70%
Dec 31, 2017 42.19%
Sep 30, 2017 -147.77%
Jun 30, 2017 -2.82%
Mar 31, 2017 -118.88%
Dec 31, 2016 -65.07%
Sep 30, 2016 68.72%
Jun 30, 2016 53.01%
Mar 31, 2016 73.38%
Dec 31, 2015 55.56%
Sep 30, 2015 32.67%
Jun 30, 2015 21.67%
Mar 31, 2015 14.15%
Dec 31, 2014 -63.40%
Sep 30, 2014 -64.33%
Jun 30, 2014 -170.75%
Mar 31, 2014 -163.39%
Dec 31, 2013 -126.31%
Sep 30, 2013 -66.12%
Jun 30, 2013 -339.69%
Mar 31, 2013 -146.09%
Dec 31, 2012 -216.49%
Sep 30, 2012 -135.33%
Jun 30, 2012 58.65%
Mar 31, 2012 39.81%
Dec 31, 2011 74.60%
Sep 30, 2011 63.80%
Jun 30, 2011 56.21%